BlackRock
OPTR

BlackRock’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BlackRock’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,575
Closed -$20K – 3196
2013
Q3 		$20K Buy
1,575
+114
+8% +$1.51K ﹤0.01% 2296
2013
Q2 		$22K Buy
+1,461
New +$21.3K ﹤0.01% 2268

BlackRock's OPTR Position: Q4 2013 in Review

BlackRock sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,575 shares — an estimated $20K sold.

BlackRock first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $22K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BlackRock reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BlackRock sold 1,575 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $20K.
  • BlackRock first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BlackRock's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $22K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BlackRock's 13F filing for Q4 2013, filed 12 Feb 2014.